CXCL10 and neoplasm: Activation of Wnt/β-catenin pathway in cancer cells inhibits secretion of CCL4 that is required for the recruitment of BATF-3 dependent dendritic cells to the tumor micro-environment, resulting in reduced levels of DC-derived CXCL10 and limited CD8+ CTL infiltration and cross-priming [14].